NIPER Develops a New Drug For Type II Diabetes
The National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), claims to have developed a new class of compounds for […]
Say something
Tags: ahmedabad, Association of Commonwealth Universities, chemical molecules, diabetes, Director, education, health, Health/Medical/Pharmaceuticals, India, Kiran Kalia, manufacturing, manufacturing process, MB Institute of Mental Health, medicine, mohali, MS, National Institute of Pharmaceutical Education, National Institute of Pharmaceutical Education and Research, Patent Filing, Rifampicin, strain, TB, tuberculosis, Type-II diabetes
-
-
Flipkart Health+ App Launched
06-04-2022
